Skip to main content
Elixir Italy - Logo
  • About us
    • Members
    • People
    • Industry & Innovation
    • Impact
  • How we work
    • Platforms
    • Communities
    • Focus Groups
    • Projects
  • Services
  • Events
  • News
  • Contacts
Home
Services

ESpritz

Command-line tool, Web application

Efficient disorder prediction tool.

Structure analysis
Università di Padova - Emblem Provided by Università di Padova
Portrait of Silvio Tosatto Primary contact name [obfuscated email]
Get started
Bio.Tools ID
espritz
Version
1.3
OS
Windows Windows icon Linux Linux icon Mac Mac icon
Documentation
General
ESpritz - User interface
Get started with ESpritz
Platforms
Provided by Tools

You may also be interested in…

INGA

Web application,  Web API

Interaction Network GO Annotator protein function predictor.

Function analysis
Università di Padova - Emblem

PyMod

Desktop application

A simple and intuitive interface between the popular molecular graphics system…

Molecular modellingProteins+1 
Università di Roma Sapienza - Emblem

MobiDB-lite

Command-line tool

MobiDB-lite is an optimized method for highly specific predictions of long…

Protein sites, features and motifs
Università di Padova - Emblem
Elixir Italy - Logo

ELIXIR Italy is the Italian Node of ELIXIR Europe and operates as the national Infrastructure for Bioinformatics. It delivers services, training, and data resources to support research, innovation, and collaboration in life sciences.

About us
  • Members
  • People
  • Industry & Innovation
  • Impact
How we work
  • Platforms
  • Communities
  • Focus Groups
  • Projects
Services
  • Full catalogue
  • Discover
  • New
  • Recently updated
Events
  • Training
News
  • Job vacancies
Contacts
Connect with us
X - LogoX/Twitter YouTube - LogoYouTube LinkedIn - LogoLinkedIn Bluesky - LogoBluesky
Newsletter

Stay updated on ELIXIR Italy’s latest news, events, and opportunities in bioinformatics and life science research.

Subscribe
© Copyright 2026 IIB - ELIXIR Italy
Privacy & Cookie Policy
CNR Elixir Europe
Funded by NextGenerationEU